Xanthinuria is an autosomal recessive disorder that presents itself through excessive excretion of xanthine in urine. Type I xanthinuria results from a deficiency of xanthine dehydrogenase (xdh); the xdh gene is located at chromosome 2p22-23. Type II xanthinuria results from deficiency of both XDH and aldehyde oxidase. The primary purpose of the study was to understand the molecular basis of xanthinuria through an analysis xdh mutations; as such they are dealing with type I xanthinuria. Subtyping xanthinuria was attempted by homozygosity mapping. Mutation detection was accomplished by PCR-SSCP screening of the entire xdh gene; all 36 exons and exon-intron junctions of the patient’s gene. The gene sequence was then confirmed. The researchers determined that the xanthinuria in the patient is linked to the xdh gene mutation; as suggested by their data. As a result a new 1658insC mutation in exon 16 of the xdh gene was identified; through the analysis of the patient’s xdh gene. The researchers demonstrated the linkage of xanthinuria to the xdh locus by homozygosity mapping. Additionally, the newly identified 1658insC mutation predicted an inactivated xdh protein. They conclude by saying that their results “reinforce the notion that mutations in the xdh gene are the underlying cause of classical xanthinuria type I.”
References:
David Levartovsky, Ayala Lagziel, Oded Sperling, Uri Liberman, Michael Yaron, Tatsuo Hosoya, Kimiyoshi Ichida and Hava Peretz. Tel Aviv Sourasky Medical Center and Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel; and The Jikey University School of Medicine, Tokyo, Japan. Published: 7 January 2000.
Additionally a Link to the Full Text is Provided Below:
You must be logged in to post a comment.